Procter & Gamble CO Form 4 insider transactions
NYSE
Christopher Kempczinski, a director at Procter & Gamble, reported the acquisition of 1,309 shares of common stock through restricted stock units.
NYSE
Director Joseph Jimenez reported acquiring 1,309 shares of Procter & Gamble common stock on October 8, 2024, through an award of Restricted Stock Units.
NYSE
Director Sheila Bonini reports acquiring 1,309 shares of Procter & Gamble common stock through restricted stock units.
NYSE
Director M. Brett Biggs reports acquisition of 1,309 shares of Procter & Gamble common stock through restricted stock units.
NYSE
Director Allen Bertrand Marc reports acquisition and disposal of Procter & Gamble common stock on October 8, 2024.
NYSE
Alexandra Keith, CEO Beauty at Procter & Gamble, reported selling shares of common stock to cover tax obligations arising from the settlement of a Restricted Stock Unit award.
NYSE
Susan Whaley, Chief Legal Officer & Secretary of Procter & Gamble, reports acquisition and disposal of company stock and stock options.
NYSE
Procter & Gamble's CEO, Jon Moeller, reports the acquisition of restricted stock units and the sale of shares to cover tax obligations.
NYSE
Jennifer L. Davis, CEO Health Care at Procter & Gamble, reports the acquisition and disposal of company stock and stock options.
NYSE
Chief Research, Development & Innovation Officer of Procter & Gamble, Moses Victor Javier Aguilar, reports acquisition of restricted stock units and stock options.
NYSE
Andre Schulten, CFO of Procter & Gamble, reports the acquisition of stock options and the sale of common stock to cover tax obligations.
NYSE
Gary A. Coombe, CEO Grooming at Procter & Gamble, reports acquisition of stock and stock options.
NYSE
Form 4: Procter & Gamble COO Shailesh Jejurikar Reports Stock Option Grant and Beneficial Ownership Changes
Chief Operating Officer of Procter & Gamble, Shailesh Jejurikar, reports acquisition of stock options and changes in beneficial ownership of common stock.
NYSE
Form 4: Procter & Gamble Executive Matthew W. Janzaruk Reports Stock Option Grant and Dividend Equivalents
Matthew W. Janzaruk, SVP Chief Accounting Officer of Procter & Gamble, reports the acquisition of stock options and dividend equivalents in the form of Restricted Stock Units (RSUs).
NYSE
Keith R. Alexandra, CEO Beauty at Procter & Gamble, reports the acquisition of stock options and adjustments to beneficial ownership of common stock.
NYSE
Ma. Fatima Francisco, a Procter & Gamble executive, reported the acquisition of stock options and changes in beneficial ownership of common stock.
NYSE
Chief Brand Officer Marc S. Pritchard reports acquisition of stock options and adjustments to beneficial ownership of Procter & Gamble stock.
NYSE
Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, reports the acquisition of stock options and changes in beneficial ownership of company stock.
NYSE
Sundar G. Raman, CEO of Fabric & Home Care at Procter & Gamble, reports the acquisition of stock options and adjustments to beneficial ownership of common stock.
NYSE
Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble, reports the acquisition of stock options and ownership of common stock.
NYSE
Alexandra Keith, CEO Beauty at Procter & Gamble, reports acquisition of stock options and changes in beneficial ownership of common stock.
NYSE
Chief Operating Officer of Procter & Gamble, Shailesh Jejurikar, reports the acquisition of stock options and adjustments to beneficial ownership of common stock.
NYSE
Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, reports the acquisition of stock options.
NYSE
Director Patricia A. Woertz reports acquiring 169 shares of Procter & Gamble common stock through restricted stock units.
NYSE
Director Robert Portman reports acquisition of Procter & Gamble restricted stock units through a grant and dividend equivalents.
NYSE
Director Ashley McEvoy acquired 169 shares of Procter & Gamble common stock through the company's 2019 Stock and Incentive Compensation Plan.
NYSE
Form 4: Procter & Gamble Director Christine M. McCarthy Reports Acquisition of Restricted Stock Units
Christine M. McCarthy, a director of Procter & Gamble, reported the acquisition of 211 restricted stock units on September 10, 2024.
NYSE
Director Terry J. Lundgren reports acquiring 204 shares of Procter & Gamble common stock and holding 40,209.8003 shares after the transaction.
NYSE
Director Christopher Kempczinski reports acquiring 169 shares of Procter & Gamble common stock through restricted stock units and dividend equivalents.
NYSE
Director Joseph Jimenez reports acquiring 268 shares of Procter & Gamble common stock through restricted stock units.